David E. Gloriam
20032020

Research activity per year

Network

Helgi B Schiöth

  • Uppsala University

External person

Robert Fredriksson

  • Uppsala University

External person

Raymond C Stevens

  • ShanghaiTech University
  • University of Southern California
  • Scripps Research Institute

External person

Malin C Lagerström

  • Uppsala University

External person

Andrzej J Bojarski

  • Institute of Pharmacology of the Polish Academy of Sciences
  • Polish Academy of Sciences

External person

Sandrine Palcy

  • Université de Bordeaux

External person

Stephen L Garland

  • GlaxoSmithKline Pharmaceuticals plc

External person

Henning Hermjakob

  • Wellcome Trust Genome Campus

External person

Ronald Frank

  • Helmholtz Center for Infection Research

External person

Vsevolod Katritch

  • Scripps Research Institute

External person

Bernhard Korn

  • German Cancer Research Center

External person

Matthew N Davies

  • King's College London

External person

Manfred Koegl

  • Resource Center for Genome Research

External person

Chris de Graaf

  • Vrije Universiteit Amsterdam

External person

Hermogenes N Jimenez

  • Lundbeck Research USA

External person

Alan Sawyer

  • European Molecular Biology Laboratory Monoclonal Core Facility
  • EMBL Monoclonal Antibodies Core Facility

External person

Friedrich W Herberg

  • University of Kassel

External person

Oda Stoevesandt

  • Babraham Bioscience Technologies

External person

Ulf Landegren

  • Uppsala University

External person

Jon Timmis

  • University of York

External person

Markus Templin

  • University of Tübingen

External person

Bojan Polic

  • Medical Faculty University of Rijeka

External person

Henrik Johansson

  • Umeå University

External person

Marius Ueffing

  • Research Center for Environmental Health

External person

Asuka Inoue

  • Tohoku University

External person

Hugo Gutiérrez-de-Terán

  • Uppsala University

External person

Christer Wingren

  • Lund University

External person

Henry Rodriguez

  • National Cancer Institute

External person

Darren R Flower

  • Aston University

External person

Serge Muyldermans

  • Vrije Universiteit Brussel

External person

Gerrit Vriend

  • Radboud University Nijmegen

External person

Steven M Foord

  • GlaxoSmithKline Pharmaceuticals plc

External person

Larry Gold

  • SomaLogic Inc.

External person

Zoltán Konthur

  • Max Planck Institute for Molecular Genetics

External person

Jörg D Hoheisel

  • German Cancer Research Center

External person

Majd A I Mirza

  • Uppsala University Hospital

External person

Stefan Dübel

  • Technische Universität Braunschweig

External person

Silvère van der Maarel

  • Leiden University Medical Center

External person

David J Sherman

  • University of Bordeaux

External person

Søren M Nielsen

  • H. Lundbeck A/S

External person

Gert Vriend

  • Radboud University Nijmegen

External person

Karl J V Nordström

  • Uppsala University

External person

Toby J Gibson

  • European Molecular Biology Laboratory, Heidelberg

External person

Sylvia Krobitsch

  • Max Planck Institute for Molecular Genetics

External person

Andrew Secker

  • University of Kent

External person

Sandra Orchard

  • Wellcome Trust Genome Campus

External person

Antoine de Daruvar

  • Université de Bordeaux

External person

T.B. Jørgensen

  • University of Copenhagen

External person

Laura Jenkins

  • University of Glasgow

External person

Johan Åqvist

  • Uppsala University

External person

Itai Benhar

  • Tel Aviv University

External person

Daniela Bertinetti

  • University of Kassel

External person

Ikuo Masuho

  • Scripps Research Institute

External person

G. Vriend

  • Radboudumc Nijmegen Medical Centre

External person

Carl A K Borrebaeck

  • Lund University

External person

Brian D Hudson

  • University of Glasgow

External person

Márton Vass

  • Vrije Universiteit Amsterdam

External person

Lars Dan Johansen

  • ChemoMetec A/S (Biz)

External person

Xin-Tian Hu

  • Chinese Academy of Sciences

External person

Michael Hust

  • Technische Universität Braunschweig

External person

Jens Engel-Andreasen

  • University of Southern Denmark

External person

Claire O’Donovan

  • Dalhousie University

External person

Michelle A Uberti

  • Lundbeck Research USA

External person

Manfred Koegl

  • German Cancer Research Center

External person

Zoltàn Konthur

  • Max Planck Institute for Molecular Genetics

External person

Silvere van der Maarel

  • Universiteit Leiden

External person

Antoine de Daruvar

  • University of Bordeaux

External person

Niall Haslam

  • European Molecular Biology Laboratory, Heidelberg

External person

Jed Zaretzki

  • Rensselaer Polytechnic Institute

External person

Birgitte H Kaae

  • Radiometer Medical ApS

External person

Volker Sievert

  • Max Planck Institute for Molecular Genetics

External person

Andrea Bortolato

  • Heptares Therapeutics Ltd

External person

Tine B. Stensbøl

  • H. Lundbeck A/S

External person

Per Sauerberg

  • Novo Nordisk A/S (Biz)

External person

Stefan Dübel

  • Technical University of Braunschweig

External person

David Juncker

  • McGill University

External person

Martin Schlapshy

  • Technische Universität München

External person

Tara Hiltke

  • National Cancer Institute

External person

Leonie Jahn

  • The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark

External person

Mathias Uhlén

  • CFB - High-throughput Molecular Bioscience

External person

Niels Plath

  • H. Lundbeck A/S

External person

Jan Kehler

  • H. Lundbeck A/S

External person

Jana Selent

  • Pompeu Fabra University

External person

Michael Kuiper

  • Leeuwarden Medical Centrum

External person

Mathias Uhlén

  • AlbaNova University Center

External person

Iwan J.P. de Esch

  • Vrije Universiteit Amsterdam
  • IOTA Pharmaceuticals

External person

Niall Haslam

  • University College

External person

Mads C Nielsen

  • University of Southern Denmark

External person

Ales Marek

  • Czech Academy of Sciences

External person

Julie Bourbeillon

  • Institut National de Recherche en Informatique et en Automatique Bordeaux-Sud Ouest

External person

Barbara Rolando

  • Università degli Studi di Torino

External person

Darren R. Flower

  • Aston University

External person

Marco L. Lolli

  • Università degli Studi di Torino

External person

Olli Kallioniemi

  • Helsingin Yliopisto

External person

Li Chiung Lin

  • University of Glasgow

External person

Tara Hiltker

  • National Cancer Institute

External person

Julie Bourbeillon

  • INRIA Bordeaux-Sud-Ouest

External person

Michael J Taussig

  • Babraham Bioscience Technologies

External person

Horst Vogel

  • Ecole Polytechnique Fédérale de Lausanne

External person

Stefan Verhoeven

  • Netherlands eScience Center

External person

X. Feng

  • National Institutes of Health

External person

Alex A. Freitas

  • University of Kent

External person

Carl Borrebaeck

  • Lund University

External person

Oda Stoevesandt

  • Babraham Research Campus

External person

Inna Larsen

  • Department of Drug Design and Pharmacology, University of Copenhagen

External person

Ian Humphrey-Smith

  • Deomed Limited

External person

Peter Woollard

  • GlaxoSmithKline Pharmaceuticals plc

External person

Madan Babu

  • MRC Laboratory of Molecular Biology
  • Medical Research Council

External person

Kirill Martemyanov

  • Scripps Research Institute

External person

Michael Snyder

  • Stanford University School of Medicine

External person

Erik Björling

  • AlbaNova University Center

External person

Nicolas Lenfant

  • Aix-Marseille Université

External person

Frank E Blaney

  • GlaxoSmithKline Pharmaceuticals plc

External person

Markus Sällman Almén

  • Uppsala University

External person

Martin H. F. Pedersen

  • Technical University of Denmark

External person

Andreas Bender

  • University of Cambridge

External person

Sebastiaan Kuhne

  • Vrije Universiteit Amsterdam

External person

Andrew B Tobin

  • University of Glasgow

External person

Tezz Quon

  • University of Glasgow

External person

Sonja Schweinsberg

  • University of Kassel

External person

Thomas J. Gardella

  • Harvard Medical School

External person

Curt Breneman

  • Rensselaer Polytechnic Institute

External person

Graeme Milligan

  • Department of Molecular Pharmacology, University of Glasgow, Glasgow, Scotland
  • University of Glasgow

External person

Amanda E Mackenzie

  • University of Glasgow

External person

Per-Åke Nygren

  • AlbaNova University Center

External person

Alessandro Giraudo

  • Università degli Studi di Torino
  • Kobenhavns Universitet

External person

Donatella Boschi

  • Università degli Studi di Torino

External person

Lars Pedersen

  • H. Lundbeck A/S

External person

Luisa Montecchi-Palazzi

  • Wellcome Trust Genome Campus

External person

Samuel Kerrien

  • Wellcome Trust Genome Campus

External person

Andrew R M Bradbury

  • Los Alamos National Laboratory

External person

Michael J Taussig

  • Babraham Research Campus

External person

Erik Bongcam-Rudloff

  • Swedish University of Agricultural Sciences

External person

Matthias Uhlen

  • AlbaNova University Center

External person

I Sadaf Farooqi

  • Wellcome Sanger Institute
  • University of Cambridge

External person

Alexander Chalikiopoulos

  • Department of Drug Design and Pharmacology

External person

Leonard Floryan

  • University of Copenhagen

External person

Jean-Philippe Pin

  • Université Fédérale Toulouse Midi-Pyrénées

External person

Sreenivas Chavali

  • MRC Laboratory of Molecular Biology

External person

David Sherman

  • INRIA Bordeaux-Sud-Ouest

External person